Quick Takeaways
- Logos Global Management LP filed SCHEDULE 13G for Tenax Therapeutics, Inc. Common Stock (TENX).
- Disclosed ownership: 9.9%.
- Date of event: 27 Feb 2026.
Logos Global Management LP - 27 Feb 2026 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock (TENX)
- Filing Manager
- Logos Global Management LP
- Reporting Manager
- Logos Global Management LP
- Symbol
- TENX
- Shares outstanding
- 6,212,121 shares
- Disclosed Ownership
- 615,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Mar 2026, 12:24:22 UTC
- Date of event
- 27 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Logos Global Management LP disclosed 9.9% ownership in Tenax Therapeutics, Inc. Common Stock (TENX) on 27 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 Mar 2026, 12:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Logos Global Management LP | 9.9% | 615,000 | 0 | 615,000 | /s/ Arsani William | Managing Partner | |
| Logos Global Management GP LLC | 9.9% | 615,000 | 0 | 615,000 | /s/ Arsani William | Managing Member | |
| Logos Global Master Fund LP | 9.9% | 615,000 | 0 | 615,000 | /s/ Arsani William | Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP | |
| Logos GP LLC | 9.9% | 615,000 | 0 | 615,000 | /s/ Arsani William | Managing Member | |
| Arsani William | 9.9% | 615,000 | 0 | 615,000 | /s/ Arsani William | Reporting person |